Bellerophon Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Warren, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Bellerophon Therapeutics, Inc. has filed 643 SEC EDGAR filings since 21 Feb 2014

SEC filing history

Showing 1-11 of 11 matching filings.

Per page
25
Current page
1
10-K/A File 001-36845

10-K/A

Filing date
17 May 2018
Reporting date
31 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-36845

10-K/A

Filing date
17 Mar 2017
Reporting date
31 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-36845

10-K

Filing date
31 Mar 2015
Reporting date
31 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .